{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T22:25:14Z","timestamp":1787955914932,"version":"build-2784847793"},"reference-count":79,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1111\/jth.15438","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T05:10:37Z","timestamp":1625116237000},"page":"3177-3192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["International multicenter, multiplatform study to validate Taipan snake venom time as a lupus anticoagulant screening test with ecarin time as the confirmatory test: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibodies"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2987-281X","authenticated-orcid":false,"given":"Gary W.","family":"Moore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul O.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5466-0448","authenticated-orcid":false,"given":"Sean","family":"Platton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8740-0194","authenticated-orcid":false,"given":"Will","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6313-2938","authenticated-orcid":false,"given":"Joseph","family":"Rigano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3420-8438","authenticated-orcid":false,"given":"Claire","family":"Pouplard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7963-1256","authenticated-orcid":false,"given":"Elaine","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7559-2579","authenticated-orcid":false,"given":"Katrien M.J.","family":"Devreese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.15438_bb0010","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15438_bb0015","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/jth.13976","article-title":"Subcommittee on Lupus anticoagulant\/Antiphospholipid antibodies. Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH","volume":"16","author":"Devreese","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15438_bb0020","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1055\/s-0033-1364185","article-title":"Recent guidelines and recommendations for laboratory detection of lupus anticoagulants","volume":"40","author":"Moore","year":"2014","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.15438_bb0025","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1111\/jth.15047","article-title":"Guidance from the Scientific and Standardisation Committee for lupus anticoagulant\/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis. Update of the guidelines for lupus anticoagulant detection and interpretation","volume":"18","author":"Devreese","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15438_bb0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2141.2012.09037.x","article-title":"Guidelines on the investigation and management of antiphospholipid syndrome","volume":"157","author":"Keeling","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.15438_bb0035","series-title":"Laboratory Testing for the Lupus Anticoagulant; Approved Guideline. CLSI Document H60\u2010A","year":"2014"},{"key":"10.1111\/jth.15438_bb0040","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/jth.14846","article-title":"Lupus anticoagulant detection in anticoagulated patients. Guidance from the Scientific and Standardization Committee for lupus anticoagulant\/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis","volume":"18","author":"Tripodi","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15438_bb0045","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1365-2141.1999.01596.x","article-title":"Lipid composition of seven APTT reagents in relation to heparin sensitivity","volume":"106","author":"Kitchen","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.15438_bb0050","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/00313020126304","article-title":"A comparison of the sensitivity of APTT reagents to the effects of enoxaparin, a low\u2010molecular weight heparin","volume":"33","author":"Ip","year":"2001","journal-title":"Pathology"},{"key":"10.1111\/jth.15438_bb0055","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/jth.14829","article-title":"Unveiling the complex effects of direct oral anticoagulants on dilute Russell\u2019s viper venom time assays","volume":"18","author":"Hillarp","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15438_bb0060","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s12185-017-2228-y","article-title":"Clinical usefulness of the dilute Russell viper venom time test for patients taking warfarin","volume":"106","author":"Kanouchi","year":"2017","journal-title":"Int J Hematol"},{"key":"10.1111\/jth.15438_bb0065","doi-asserted-by":"crossref","first-page":"E166","DOI":"10.1002\/ajh.25465","article-title":"High frequency of false\u2010positive results of aPTT\u2010based lupus anticoagulant tests in patients receiving argatroban","volume":"94","author":"Villalba","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1111\/jth.15438_bb0070","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/rth2.12264","article-title":"The effect of unfractionated heparin, enoxaparin, and danaparoid on lupus anticoagulant testing: Can activated carbon eliminate false\u2010positive results?","volume":"4","author":"De Kesel","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1111\/jth.15438_bb0075","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/antib5040022","article-title":"Current controversies in lupus anticoagulant detection","volume":"5","author":"Moore","year":"2016","journal-title":"Antibodies"},{"key":"10.1111\/jth.15438_bb0080","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1477-9560-5-12","article-title":"Combining Taipan snake venom time\/Ecarin time screening with the mixing studies of conventional assays increases detection rates of lupus anticoagulants in orally anticoagulated patients","volume":"5","author":"Moore","year":"2007","journal-title":"Thromb J"},{"key":"10.1111\/jth.15438_bb0085","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1515\/cclm-2019-1248","article-title":"Mixing studies for lupus anticoagulant: mostly no, sometimes yes","volume":"58","author":"Moore","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"10.1111\/jth.15438_bb0090","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1111\/jth.14894","article-title":"Direct oral anticoagulant adsorption: Impact on lupus anticoagulant testing \u2010 review of the literature and evaluation on spiked and patient samples","volume":"18","author":"De Kesel","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15438_bb0095","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1055\/s-0038-1649701","article-title":"The Textarin\/Ecarin ratio: a confirmatory test for lupus anticoagulants","volume":"70","author":"Triplett","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15438_bb0100","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/jcp.47.6.497","article-title":"The Taipan snake venom time: a new test for lupus anticoagulant","volume":"47","author":"Rooney","year":"1994","journal-title":"J Clin Pathol"},{"key":"10.1111\/jth.15438_bb0105","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/01.mbc.0000061283.28953.39","article-title":"The Ecarin time is an improved confirmatory test for the Taipan snake venom time in warfarinized patients with lupus anticoagulants","volume":"14","author":"Moore","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.15438_bb0110","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1111\/j.1538-7836.2011.04395.x","article-title":"Detection of lupus anticoagulant in the presence of rivaroxaban using Taipan snake venom time","volume":"9","author":"van Os","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15438_bb0115","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1111\/ijlh.12611","article-title":"The Taipan snake venom time can be used to detect lupus anticoagulant in patients treated by rivaroxaban","volume":"39","author":"Pouplard","year":"2017","journal-title":"Int J Lab Hematol"},{"key":"10.1111\/jth.15438_bb0120","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1055\/s-0038-1648949","article-title":"Evaluation of recently described tests for detection of the lupus anticoagulant","volume":"72","author":"Forastiero","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15438_bb0125","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0049-3848(99)00096-1","article-title":"Lupus anticoagulant testing with optical end point automation","volume":"96","author":"Luddington","year":"1999","journal-title":"Thromb Res"},{"key":"10.1111\/jth.15438_bb0130","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1055\/s-0037-1614567","article-title":"The sensitivity and specificity of commercial reagents for the detection of lupus anticoagulant show marked differences in performance between photo\u2010optical and mechanical coagulometers","volume":"81","author":"Lawrie","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15438_bb0135","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/MBC.0b013e3283256037","article-title":"The utility of the Taipan snake venom assay in assessing lupus anticoagulant status in individuals receiving or not receiving an oral vitamin K antagonist","volume":"20","author":"Parmar","year":"2009","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.15438_bb0140","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/MBC.0000000000000486","article-title":"Taipan snake venom time coupled with ecarin time testing enhances lupus anticoagulant detection in non\u2010anticoagulated patients","volume":"27","author":"Moore","year":"2016","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.15438_bb0145","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1111\/jth.12917","article-title":"Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome","volume":"13","author":"Arachchillage","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15438_bb0150","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/jth.12537","article-title":"Testing for antiphospholipid antibodies with solid phase assays: guidance from the SSC of the ISTH","volume":"12","author":"Devreese","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15438_bb0155","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/jcp.44.11.885","article-title":"Guidelines on testing for the lupus anticoagulant. Lupus anticoagulant working party on behalf of the BCSH Haemostasis and Thrombosis Task Force","volume":"44","author":"Machin","year":"1991","journal-title":"J Clin Pathol"},{"key":"10.1111\/jth.15438_bb0160","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1309\/6HYE47508GWTTC4E","article-title":"A simplified algorithm for the laboratory detection of lupus anticoagulants: utilization of two automated integrated tests","volume":"124","author":"Zhang","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1111\/jth.15438_bb0165","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/ijlh.12006","article-title":"Lupus anticoagulant detection: out of control?","volume":"35","author":"Moore","year":"2013","journal-title":"Int J Lab Haematol"},{"key":"10.1111\/jth.15438_bb0170","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/107602960200800206","article-title":"Reference intervals of the dilute tissue thromboplastin inhibition and dilute Russell's viper venom tests revisited","volume":"8","author":"Gerbutavicius","year":"2002","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1111\/jth.15438_bb0175","series-title":"Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline (Third edition)","year":"2008"},{"key":"10.1111\/jth.15438_bb0180","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1055\/s-0038-1627480","article-title":"International Council for Standardization in Haematology (ICSH) Recommendations for laboratory measurement of direct oral anticoagulants","volume":"118","author":"Gosselin","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15438_bb0185","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/ajh.25836","article-title":"Alternative assays to dRVVT and aPTT for lupus anticoagulant detection","volume":"95","author":"Moore","year":"2020","journal-title":"Am J Hematol"},{"key":"10.1111\/jth.15438_bb0190","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1111\/j.1538-7836.2010.04090.x","article-title":"Laboratory investigation of lupus anticoagulants: mixing studies are sometimes required","volume":"8","author":"Favaloro","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15438_bb0195","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/j.1365-2141.2000.02466.x","article-title":"The importance of locally derived reference ranges and standardized calculation of dilute Russell's viper venom time results in screening for lupus anticoagulant","volume":"111","author":"Gardiner","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.15438_bb0200","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/jth.13678","article-title":"Variability of cut\u2010off values for the detection of lupus anticoagulants. Results of an international multicenter multiplatform study","volume":"15","author":"Tripodi","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15438_bb0205","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1515\/cclm-2012-0382","article-title":"Cooperation experience in a multicentre study to define the upper limits in a normal population for the diagnostic assessment of the functional lupus anticoagulant assays","volume":"51","author":"Pradella","year":"2013","journal-title":"Clin Chem Lab Med"},{"key":"10.1111\/jth.15438_bb0210","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/jth.14669","article-title":"Lupus anticoagulant assay cut\u2010offs vary between reagents even when derived from a common set of normal donor plasmas","volume":"18","author":"Moore","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15438_bb0215","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1532\/LH96.05031","article-title":"Recommendations for evaluation of coagulation analyzers","volume":"12","author":"Gardiner","year":"2006","journal-title":"Lab Hematol"},{"key":"10.1111\/jth.15438_bb0220","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1751-553X.2007.00999.x","article-title":"Evaluation and performance characteristics of the coagulation system: ACL TOP analyzer \u2010 HemosIL reagents","volume":"31","author":"Milos","year":"2009","journal-title":"Int J Lab Hematol"},{"key":"10.1111\/jth.15438_bb0225","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1515\/cclm-2013-1094","article-title":"Evaluation of the automated coagulation analyzer CS\u20105100 and its utility in high throughput laboratories","volume":"52","author":"Ratzinger","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"10.1111\/jth.15438_bb0230","first-page":"41731","article-title":"Performance evaluation of a new Stago\u00ae automated haemostasis analyser: the STA R Max\u00ae 2","author":"Cupaiolo","year":"2019","journal-title":"Int J Lab Hematol"},{"key":"10.1111\/jth.15438_bb0235","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/ijlh.12918","article-title":"The importance of commutability in material used for quality control purposes","volume":"41","author":"Jennings","year":"2019","journal-title":"Int J Lab Hematol"},{"key":"10.1111\/jth.15438_bb0240","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1309\/AJCP60ZGXCJKRMJO","article-title":"Inaccuracy of a \"spiked curve\" for monitoring unfractionated heparin therapy","volume":"135","author":"Gausman","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1111\/jth.15438_bb0245","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1111\/jth.12308","article-title":"Performance of coagulation tests in patients on therapeutic doses of dabigatran: a cross\u2010sectional pharmacodynamic study based on peak and trough plasma levels","volume":"11","author":"Hawes","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15438_bb0250","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000081505","article-title":"The Ecarin clotting time, a universal method to quantify direct thrombin inhibitors","volume":"33","author":"Nowak","year":"2004","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1111\/jth.15438_bb0255","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3390\/toxins8100284","article-title":"Metalloproteases affecting blood coagulation, fibrinolysis and platelet aggregation from snake venoms: definition and nomenclature of interaction sites","volume":"8","author":"Kini","year":"2016","journal-title":"Toxins"},{"key":"10.1111\/jth.15438_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116835","article-title":"Monitoring low molecular weight heparins at therapeutic levels: dose\u2010responses of, and correlations and differences between aPTT, anti\u2010factor Xa and thrombin generation assays","volume":"10","author":"Thomas","year":"2015","journal-title":"PLoS One"},{"issue":"Suppl 2","key":"10.1111\/jth.15438_bb0265","doi-asserted-by":"crossref","first-page":"e24S","DOI":"10.1378\/chest.11-2291","article-title":"Parenteral anticoagulants: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence\u2010Based Clinical Practice Guidelines","volume":"141","author":"Garcia","year":"2012","journal-title":"Chest"},{"key":"10.1111\/jth.15438_bb0270","doi-asserted-by":"crossref","first-page":"28660","DOI":"10.1074\/jbc.272.45.28660","article-title":"Inhibition of meizothrombin and meizothrombin(desF1) by heparin cofactor II","volume":"272","author":"Han","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.15438_bb0275","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1309\/AJCP4SPPLG5XVIXF","article-title":"Lupus anticoagulant testing: performance and practices by North American clinical laboratories","volume":"134","author":"Dembitzer","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1111\/jth.15438_bb0280","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1055\/s-0033-1334865","article-title":"Comparison of six dilute Russell viper venom time lupus anticoagulant screen\/confirm assay kits","volume":"39","author":"McGlasson","year":"2013","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.15438_bb0285","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/ced.14229","article-title":"Taipan snake venom time for antiphospholipid syndrome solves a 20\u2010year diagnostic challenge","volume":"45","author":"Cunliffe","year":"2020","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/jth.15438_bb0290","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0049-3848(01)00420-0","article-title":"Dilute prothrombin\u2010time based lupus ratio test. Integrated LA testing with recombinant tissue thromboplastin","volume":"105","author":"Liest\u00f8l","year":"2002","journal-title":"Thromb Res"},{"key":"10.1111\/jth.15438_bb0295","first-page":"673","article-title":"A new lupus anticoagulant test based on dilute prothrombin time","volume":"114","author":"Mackie","year":"2004","journal-title":"Thromb Res"},{"key":"10.1111\/jth.15438_bb0300","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00001721-200204000-00013","article-title":"The Activated Seven Lupus Anticoagulant (ASLA) assay: a new test for lupus anticoagulants (LAs). Evidence that some LAs are detectable only in extrinsic pathway\u2010based assays","volume":"13","author":"Moore","year":"2002","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.15438_bb0305","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1515\/cclm-2016-0245","article-title":"Dilute Russell's viper venom time reagents in lupus anticoagulant testing: a well\u2010considered choice","volume":"55","author":"Depreter","year":"2017","journal-title":"Clin Chem Lab Med"},{"key":"10.1111\/jth.15438_bb0310","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/0961203317711773","article-title":"Newly developed dilute Russell's viper venom reagents for lupus anticoagulant detection with improved specificity","volume":"27","author":"Moore","year":"2018","journal-title":"Lupus"},{"key":"10.1111\/jth.15438_bb0315","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/jth.15241","article-title":"Anti\u2010\u03b22\u2010glycoprotein I and anti\u2010prothrombin antibodies cause lupus anticoagulant through different mechanisms of action","volume":"19","author":"Noordermeer","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15438_bb0320","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/jth.14765","article-title":"Tetra positive thrombotic antiphospholipid syndrome: major contribution of anti\u2010phosphatidyl\u2010serine\/prothrombin antibodies to lupus anticoagulant activity","volume":"18","author":"Cattini","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15438_bb0325","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/jth.15199","article-title":"Insight into the hypercoagulable state of high\u2010risk thrombotic APS patients: contribution of a\u03b22GPI and aPS\/PT antibodies","volume":"19","author":"Pontara","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15438_bb0330","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1538-7836.2009.03674.x","article-title":"Clinical course of high\u2010risk patients diagnosed with antiphospholipid syndrome","volume":"8","author":"Pengo","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15438_bb0335","article-title":"Characteristics of antiphospholipid antibody positive patients in antiphospholipid syndrome alliance for clinical trials and international networking","author":"Sevim","year":"2020","journal-title":"Arthritis Care Res"},{"key":"10.1111\/jth.15438_bb0340","doi-asserted-by":"crossref","first-page":"490","DOI":"10.5858\/2009-0474-OA.1","article-title":"International normalized ratio versus plasma levels of coagulation factors in patients on vitamin K antagonist therapy","volume":"135","author":"Gulati","year":"2011","journal-title":"Arch Pathol Lab Med"},{"key":"10.1111\/jth.15438_bb0345","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1177\/0961203314558859","article-title":"Lupus anticoagulant\u2010hypoprothrombinemia syndrome: report of two cases and review of the literature","volume":"24","author":"Mulliez","year":"2015","journal-title":"Lupus"},{"key":"10.1111\/jth.15438_bb0350","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/j.1538-7836.2010.03807.x","article-title":"No more mixing tests required for integrated assay systems in the laboratory diagnosis of lupus anticoagulants?","volume":"8","author":"Devreese","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15438_bb0355","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/jth.13020","article-title":"Mixing studies in lupus anticoagulant testing are required at least in some type of samples","volume":"13","author":"Devreese","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15438_bb0360","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/rth2.12006","article-title":"Application of different lupus anticoagulant diagnostic algorithms to the same assay data leads to interpretive discrepancies in some samples","volume":"1","author":"Moore","year":"2017","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1111\/jth.15438_bb0365","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1160\/TH12-11-0850","article-title":"Laboratory diagnostic outcome applying detection criteria recommended by the scientific and standardisation committee of the ISTH on lupus anticoagulant","volume":"110","author":"Chantarangkul","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15438_bb0370","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJM198107303050502","article-title":"Acquired vitamin K\u2010dependent carboxylation deficiency in liver disease","volume":"305","author":"Blanchard","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.15438_bb0375","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1365-2257.2004.00644.x","article-title":"Alteration in the laboratory profile of a lupus anticoagulant in a patient with non\u2010Hodgkin's lymphoma","volume":"26","author":"Moore","year":"2004","journal-title":"Clin Lab Haematol"},{"key":"10.1111\/jth.15438_bb0380","unstructured":"PRAC recommendations on signals Adopted at the 8\u201311 April2019 PRAC meeting. EMA Pharmacovigilance Risk Assessment Committee (PRAC.). https:\/\/www.ema.europa.eu\/en\/documents\/prac\u2010recommendation\/prac\u2010recommendations\u2010signals\u2010adopted\u20108\u201011\u2010april\u20102019\u2010prac\u2010meeting_en.pdf. Accessed November 5, 2020."},{"key":"10.1111\/jth.15438_bb0385","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/rth2.12287","article-title":"Direct oral anticoagulants in antiphospholipid syndrome with venous thromboembolism: impact of the European Medicines Agency guidance","volume":"4","author":"Fazili","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1111\/jth.15438_bb0390","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/jth.15438_bb0395","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/bjh.16431","article-title":"What is the appropriate anticoagulation strategy for thrombotic antiphospholipid syndrome?","volume":"189","author":"Arachchillage","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.15438_bb0400","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1111\/jth.14935","article-title":"Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis","volume":"18","author":"Zuily","year":"2020","journal-title":"J Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15438","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.15438","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622005323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622005323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15438","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:29:55Z","timestamp":1761535795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622005323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":79,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1538783622005323"],"URL":"https:\/\/doi.org\/10.1111\/jth.15438","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"International multicenter, multiplatform study to validate Taipan snake venom time as a lupus anticoagulant screening test with ecarin time as the confirmatory test: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibodies","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.15438","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}